1. A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid‐targeted bromodomain and extra‐terminal domain inhibitor. Issue 5 (18th December 2021) Authors: Brown, Jack A.; Bal, Joanne; Simeoni, Monica; Williams, Peter; Mander, Palwinder K.; Soden, Peter E.; Daga, Shruti; Fahy, William A.; Wong, Gabriel K.; Bloomer, Jackie C.; Erwig, Lars; Cui, Yi; Fernando, Disala; Carnaghan, Helen; Banham‐Hall, Edward J.; Hopkins, Sarah; Davis, Bill G.; Oliveira, J... Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 5(2022) Page Start: 2140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome. (April 2023) Authors: Begg, Malcolm; Amour, Augustin; Jarvis, Emily; Tang, Teresa; Franco, Sara Santos; Want, Andrew; Beerahee, Misba; Fernando, Disala; Karkera, Yakshitha; Sander, Clare; Southworth, Thomas; Singh, Dave; Clark, Jonathan; Nejentsev, Sergey; Okkenhaug, Klaus; Condliffe, Alison; Chandra, Anita; Cahn, Ant... Journal: Pulmonary pharmacology & therapeutics Issue: Volume 79(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study. Issue 2 (3rd December 2018) Authors: Ellis, Joanne; van Maurik, Andre; Fortunato, Lea; Gisbert, Sophie; Chen, Keguan; Schwartz, Ann; McHugh, Simon; Want, Andrew; Santos Franco, Sara; Oliveira, Joao‐Joaquim; Price, Jeffrey; Coles, Alasdair; Brown, Kim; Su, Donggang; Craigen, Jenny L.; Yang, Jiansong; Brett, Sara; Davis, Bill; Cheriya... Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 2(2019) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of the safety, pharmacokinetics and pharmacodynamics of GSK3335065, an inhibitor of kynurenine monooxygenase, in a randomised placebo‐controlled first‐in‐human study in healthy volunteers. Issue 2 (22nd August 2021) Authors: Fernando, Disala; Dimelow, Richard; Gorey, Ciara; Zhu, Xinyi; Muya, Catherine; Parker, Connie; Wright, Wayne; Soleman, Sara; Walsh, Sarah; Crause, Madelein; Vlasakakis, Georgios; Guiney, William; Robertson, Nicola; Bergeal, Marylise; Cui, Yi; Krug, Alexander W.; Uings, Iain Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 2(2022) Page Start: 865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CCL20 neutralization by a monoclonal antibody in healthy subjects selectively inhibits recruitment of CCR6+ cells in an experimental suction blister. (22nd April 2017) Authors: Bouma, Gerben; Zamuner, Stefano; Hicks, Kirsty; Want, Andrew; Oliveira, João; Choudhury, Arpita; Brett, Sara; Robertson, Darren; Felton, Leigh; Norris, Virginia; Fernando, Disala; Herdman, Michael; Tarzi, Ruth Journal: British journal of clinical pharmacology Issue: Volume 83:Number 9(2017) Page Start: 1976 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of Dynamic Contrast‐Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study. Issue 2 (27th March 2022) Authors: Cheriyan, Joseph; Roberts, Alexandra; Roberts, Caleb; Graves, Martin J.; Patterson, Ilse; Slough, Rhys A.; Schroyer, Rosemary; Fernando, Disala; Kumar, Subramanya; Lee, Sarah; Parker, Geoffrey J.M.; Sarov‐Blat, Lea; McEniery, Carmel; Middlemiss, Jessica; Sprecher, Dennis; Janiczek, Robert L. Journal: Journal of magnetic resonance imaging Issue: Volume 56:Issue 2(2022) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification, preclinical profile, and clinical proof of concept of an orally bioavailable pro‐drug of miridesap. (11th February 2020) Authors: Richards, Duncan; Bamford, Mark; Liefaard, Lia; Haque, Nazneen; Lewis, Gareth; Storey, Jim; Fernando, Disala; Kumar, Subramanya; Thompson, Douglas; Holmes, Duncan S. Journal: British journal of pharmacology Issue: Volume 177:Number 8(2020) Page Start: 1853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. In vivo affinity and target engagement in skin and blood in a first‐time‐in‐human study of an anti‐oncostatin M monoclonal antibody. (12th July 2018) Authors: Reid, Juliet; Zamuner, Stefano; Edwards, Ken; Rumley, Sally‐Anne; Nevin, Katherine; Feeney, Maria; Zecchin, Chiara; Fernando, Disala; Wisniacki, Nicolas Journal: British journal of clinical pharmacology Issue: Volume 84:Number 10(2018) Page Start: 2280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor. Issue 6 (17th November 2020) Authors: Joshi, Samit R.; Fernando, Disala; Igwe, Stephanie; McKenzie, Litza; Krishnatry, Anu S.; Halliday, Fiona; Zhan, Joyce; Greene, Thomas J.; Xu, Jianfeng; Ferron‐Brady, Geraldine; Lataillade, Max; Min, Sherene Journal: Pharmacology research & perspectives Issue: Volume 8:Issue 6(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗